Table 4. Association of the ARFs and the macroangiopathy measurement results.
| Complication Risk factor | Partial regression coefficient ± SE | Odds ratio | 95% confidence interval | P value |
|---|---|---|---|---|
| ASO | ||||
| ABI classification [T. ≤ 0.9] | 6.05 ± 0.76 | 426 | 91.9 to 1970 | < 0.001 |
| ABI classification [T. < 1.0 but > 0.9] | 2.61 ± 0.61 | 13.6 | 4.16 to 44.70 | < 0.001 |
| Male (female) | 1.80 ± 0.86 | 6.05 | 1.11 to 32.9 | < 0.05 |
| CAVI | 0.20 ± 0.10 | 1.22 | 1.00 to 1.49 | < 0.05 |
| Height | −0.11 ± 0.05 | 0.89 | 0.81 to 0.98 | < 0.05 |
| CAD | ||||
| Hyperlipidemia | 0.64 ± 0.28 | 1.91 | 1.10 to 3.31 | < 0.05 |
| Male | 0.57 ± 0.23 | 1.77 | 1.14 to 2.76 | < 0.05 |
| CAVI | 0.18 ± 0.06 | 1.20 | 1.07 to 1.35 | < 0.01 |
| Age | 0.03 ± 0.01 | 1.03 | 1.01 to 1.05 | < 0.01 |
| SBP | 0.01 ± 0.01 | 1.01 | 1.00 to 1.02 | < 0.05 |
| Stroke | ||||
| ABI classification [T. ≤ 0.9] | 1.45 ± 0.54 | 4.26 | 1.47 to 12.30 | < 0.001 |
| ABI classification [T. < 1.0 but > 0.9] | 0.90 ± 0.33 | 2.47 | 1.30 to 4.69 | < 0.001 |
| Hypertension | 0.69 ± 0.32 | 2.00 | 1.06 to 3.77 | < 0.01 |
| CAVI | 0.19 ± 0.06 | 1.19 | 1.05 to 1.35 | < 0.001 |
| Age | 0.03 ± 0.01 | 1.03 | 1.01 to 1.06 | < 0.001 |
| Any of macroangiopathy | ||||
| ABI classification [T. ≤ 0.9] | 3.03 ± 0.84 | 20.7 | 3.98 to 10.8 | < 0.001 |
| ABI classification [T. < 1.0 but > 0.9] | 1.11 ± 0.28 | 3.02 | 1.75 to 5.23 | < 0.001 |
| Hypertension | 0.75 ± 0.21 | 2.13 | 1.40 to 3.23 | < 0.001 |
| Male | 0.64 ± 0.20 | 1.91 | 1.29 to 2.81 | < 0.01 |
| CAVI | 0.26 ± 0.06 | 1.29 | 1.14 to 1.47 | < 0.001 |
| Age | 0.04 ± 0.01 | 1.04 | 1.02 to 1.06 | < 0.001 |
ABI, ankle brachial pressure index; ASO, arteriosclerosis obliterans; CAVI, cardio ankle vascular index; SBP, systolic blood pressure; SE, standard error